American Well Corporation Class A (AMWL)

In the past six months, American Well Corp. stock has declined by 17.41%, but has increased by 61.8% since the start of 2026, trading at $7.9350 as of May 9, 2026. The stock has traded between $3.71 and $9.15 over the past 52 weeks. Recent events include the Q1 2026 earnings report, which highlighted progress toward profitability despite an 18% year-over-year revenue decrease to $54.9 million. The company reported a reduced net loss of $10.3 million and an improved adjusted EBITDA loss of $3.1 million. Amwell reaffirmed its full-year 2026 revenue guidance of $195 million to $205 million and improved its adjusted EBITDA loss expectations to a range of $16 million to $12 million, with a target of achieving positive cash flow from operations in Q4 2026. The divestiture of Amwell Psychiatric Care in 2025 also impacted revenue guidance.

American Well Corp. experiences demand seasonality for its products and services, with executives noting "normal seasonality in visit volumes." In Q1 2026, Amwell observed a "nice seasonal boost" in visit volumes, followed by the expected seasonality setting in. This seasonality is also reflected in the company's Q2 2026 outlook, which anticipates normal seasonality in visit volumes.

American Well Corporation (Amwell) is a digital health company that operates a hybrid care delivery enablement platform, connecting providers, payers, patients, and innovators to facilitate access to more affordable and higher-quality care. The company primarily operates in the Healthcare sector, specifically within the Health Information Services and Packaged Software industries. Amwell's major products and services revolve around its comprehensive, cloud-based Amwell Platform, which supports a wide array of digital health needs, from urgent and acute care to post-acute care, chronic care management, and healthy living. The Amwell Platform is a cloud-based enablement platform for scalable healthcare experiences across all care settings. Amwell Carepoint includes devices like proprietary carts and TV kits that transform existing tablets and TVs into digital access points in clinical settings. Amwell Converge is a platform integrating digital care into in-person, automated, and virtual care settings. The company also provides a Behavioral Health platform offering mental health services, including therapy and pediatrics. Specialty Care Programs include dermatology, musculoskeletal care, second opinion, and cardiometabolic care. Amwell Medical Group (AMG) Network Services provides primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Professional Services offers implementation support, workflow design, systems integration, and service expansion.

American Well Corporation operates in all 50 United States, working with 55 health plans, supporting over 36,000 employers, and representing more than 80 million covered lives. Amwell collaborates with 240 of the nation's largest health systems, encompassing over 2,000 hospitals. Internationally, Amwell has a presence through a partnership with Meuhedet in Israel.

Amwell maintains a strong brand reputation within the telehealth industry, having been recognized as the "Best Overall Telehealth Solution" by the MedTech Breakthrough Awards in 2020. The company is positioned as a top-three US telehealth platform provider by enterprise footprint. Amwell has focused on its strategic evolution towards a SaaS-based technology-enabled care platform, emphasizing enterprise integrations, regulatory compliance, and platform scalability. The company has also expanded its offerings, including a cardiometabolic program through a partnership with DarioHealth, and integrated AI into its platform for predictive analytics in behavioral health. Strategic partnerships, such as the contract renewal with Elevance Health and its role in a Leidos-led partnership supporting the U.S. Defense Health Agency's Digital First Program, further underscore its strong standing and reputation.

American Well Corporation is owned by a mix of institutional and individual investors. Institutional shareholders hold approximately 33.31% of the company's shares, while insiders hold about 51.82%. Major institutional owners include Morgan Stanley, Vanguard Group Inc, and BlackRock, Inc., among others. Key individual insider owners include Keith Anderson, Brendan P. Ogrady, and Robert Thomas Webb, among others.